Search Results - "Smyth, John F"
-
1
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Published in Cancer research (Chicago, Ill.) (01-01-2012)“…Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell lines; however, the in vitro and in vivo interdependence of…”
Get full text
Journal Article -
2
Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients
Published in Clinical cancer research (15-06-2007)“…Purpose: To evaluate the efficacy of the aromatase inhibitor letrozole in preselected estrogen receptor (ER)–positive relapsed epithelial ovarian cancer…”
Get full text
Journal Article -
3
WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin α3
Published in Cancer research (Chicago, Ill.) (01-06-2009)“…Abstract The WW domain–containing oxidoreductase (WWOX) gene is located at FRA16D, a common fragile site involved in human cancer. Targeted deletion of Wwox in…”
Get full text
Journal Article -
4
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
Published in Cancer research (Chicago, Ill.) (01-08-2005)“…The majority of ovarian cancer patients are treated with platinum-based chemotherapy, but the emergence of resistance to such chemotherapy severely limits its…”
Get full text
Journal Article -
5
Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
Published in Endocrine-related cancer (01-12-2005)“…Estrogens play a significant role in the development, growth, invasion and metastasis of ovarian tumors. The transcriptional program regulated by 17β-estradiol…”
Get full text
Journal Article -
6
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling
Published in Molecular cancer therapeutics (01-01-2007)“…Pertuzumab (Omnitarg, rhuMab 2C4) is a humanized monoclonal antibody, which inhibits HER2 dimerization. Because it has shown some clinical activity in ovarian…”
Get full text
Journal Article -
7
Insulin-like Growth Factor Binding Proteins IGFBP3, IGFBP4, and IGFBP5 Predict Endocrine Responsiveness in Patients with Ovarian Cancer
Published in Clinical cancer research (01-03-2007)“…Purpose: This study sought to explore the predictive value of the insulin-like growth factor (IGF) binding proteins (IGFBP) as markers of response in ovarian…”
Get full text
Journal Article -
8
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
Published in Nature genetics (01-07-2003)“…Epithelial ovarian cancer (EOC), the leading cause of death from gynecological malignancy, is a poorly understood disease. The typically advanced presentation…”
Get full text
Journal Article -
9
The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates
Published in Clinical cancer research (15-08-2005)“…Purpose: The IgLON family of cell adhesion molecules, comprising OPCML, HNT, LSAMP, and NEGR1, has recently been linked to cancer, through two of its members…”
Get full text
Journal Article -
10
Phase I Clinical and Pharmacokinetic Study of Plitidepsin as a 1-Hour Weekly Intravenous Infusion in Patients with Advanced Solid Tumors
Published in Clinical cancer research (15-05-2008)“…Purpose: Plitidepsin, given as a 1-hour weekly i.v. infusion for 3 consecutive weeks during a 4-week treatment cycle, was investigated in patients with solid…”
Get full text
Journal Article -
11
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect
Published in Molecular cancer therapeutics (01-02-2004)“…Oxaliplatin, licensed for colorectal cancer chemotherapy, damages DNA by generating intrastrand and interstrand cross-links and can induce apoptosis via a…”
Get full text
Journal Article -
12
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Published in The Journal of clinical investigation (01-10-2009)“…Cytokines orchestrate the tumor-promoting interplay between malignant cells and the immune system. In many experimental and human cancers, the cytokine…”
Get full text
Journal Article -
13
Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells
Published in Clinical cancer research (01-12-2002)“…Purpose: To investigate the expression and function of neuregulin (NRG) isoforms in ovarian cancer cell lines and tumor samples. Experimental Design:…”
Get full text
Journal Article -
14
Antisense Bcl-xl Down-Regulation Switches the Response to Topoisomerase I Inhibition from Senescence to Apoptosis in Colorectal Cancer Cells, Enhancing Global Cytotoxicity
Published in Clinical cancer research (01-07-2003)“…Purpose: To identify determinants of the effect of antisense-mediated Bcl-xl down-regulation (Bcl-xl knockdown) on the response of colorectal cancer cells to…”
Get full text
Journal Article -
15
The Old Order Changeth – A valedictory from the Editor-in-Chief
Published in European journal of cancer (1990) (01-12-2010)Get full text
Journal Article -
16
Association of galectin-3 expression with melanoma progression and prognosis
Published in European journal of cancer (1990) (01-04-2012)“…Abstract Aims Galectin-3 plays an important role in adhesion, proliferation, differentiation, angiogenesis and metastasis in multiple tumours. To investigate…”
Get full text
Journal Article -
17
Endometrioid Epithelial Ovarian Cancer : 20 Years of Prospectively Collected Data From a Single Center
Published in Cancer (15-05-2008)“…Clinicopathological features and outcome of women with endometrioid and serous ovarian adenocarcinoma were compared. Between 1984 and 2004, baseline and…”
Get full text
Journal Article -
18
Communication as important as cure
Published in European journal of cancer (1990) (01-01-2009)Get full text
Journal Article -
19
What to do after winning the Nobel Prize – Work harder
Published in European journal of cancer (1990) (01-02-2009)Get full text
Journal Article -
20
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer
Published in Gynecologic oncology (01-09-2007)“…Abstract Objective To explore the predictive value of estrogen-regulated gene changes as indicators of sensitivity in ovarian cancer patients treated with the…”
Get full text
Journal Article